deltatrials
Completed PHASE3 NCT00574249

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

A Multi-center, Randomized, Vehicle-Controlled Study to Assess the Efficacy and Safety of Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)

Sponsor: Abbott

Conditions Chronic Plaque Psoriasis
Interventions Calcipotriol/Betamethasone Ointment adalimumab placebo (vehicle ointment)
Updated 7 times since 2017 Last updated: Apr 11, 2011 Started: Nov 30, 2007 Primary completion: Oct 31, 2008

A PHASE3 clinical study on Chronic Plaque Psoriasis, this trial is completed. The trial is conducted by Abbott and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott
Data source: Abbott

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalst, Belgium, Aberdeen, United Kingdom, Alicante, Spain, Amsterdam, Netherlands, Ankara, Turkey (Türkiye), Arhus C, Denmark, Athens, Greece, Barcelona, Spain, Basel, Switzerland, Benevento, Italy and 106 more location s